12:00 AM
Jan 10, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Status

VX15/2503: Phase I start

This month, Vaccinex will begin a dose-escalation Phase I trial to evaluate VX15/2503 in up to 54...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >